Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Sep 26;6(10):1015–1025. doi: 10.1158/1940-6207.CAPR-13-0172

Figure 2.

Figure 2

Effect of ACS combination treatment on pancreatic tumor incidence and tumor multiplicity. (A and C) Tumor incidence is determined by percentage of animals with pancreatic cancer. (B and D) Tumor multiplicity is calculated as number of pancreatic cancers per hamster. The Statistical significance was determined by one-way ANOVA followed by Dunnett's multiple comparison test post hoc analysis. *, p<0.05; **, p<0.01; ***, p<0.001 represents statistical significance between BOP (N-nitrosobis (2-oxopropyl) amine) carcinogen control and ACS treatment groups.